Does Roux-en-Y gastrectomy for gastric cancer influence glucose homeostasis in lean patients?

Surgical Endoscopy

Volumn 27, Issue 8, 2013, Pages 2829-2835

  Hayashi, Silvia Y ^a   Faintuch, Joel ^a   Yagi, Osmar K ^a   Yamaguchi, Camila M ^a   Faintuch, Jacob J ^a   Cecconello, Ivan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diabetes mellitus; Fasting blood glucose; Gastric cancer; HbA1c; New onset diabetes; Roux en Y gastric bypass; Subtotal gastrectomy; Total gastrectomy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; FEMALE; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; STOMACH BYPASS; STOMACH CANCER; TOTAL STOMACH RESECTION; WEIGHT REDUCTION;

AGED; ANASTOMOSIS, ROUX-EN-Y; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; THINNESS; TREATMENT OUTCOME;

EID: 84881372100     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-013-2829-3     Document Type: Article

References (22)

1. Yamamoto H, Tsuchihashi H, Akabori H, Naitoh H, Maegawa H, Tani T (2008) Postprandial hyperglycemia after a gastrectomy and the prediabetic state: a comparison between a distal and total gastrectomy. Surg Today 38:685-690
2. Salehi A, Chen D, Hakanson R, Nordin G, Lundquist I (1999) Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro-insular axis in mice. J Physiol 514:579-591
3. Yoshikawa T, Noguchi Y, Nomura K, Fukuzawa K, Makino T, Tsuburaya A, Imada T, Matsumoto A (1996) Alimentary hyperglycemia in patients with subtotal gastrectomy is associated with decreased insulin secretion but not with insulin resistance. Int Surg 81:32-35
4. Lanzarini E, Csendes A, Lembach H, Molina J, Gutierrez L, Silva J (2010) Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux-en-Y reconstruction: retrospective study. World J Surg 34:2098-2102
5. Cai JL, Li BQ, Zheng C, Lin XK, Yin K, Xu JR, Xu LB (2011) Impact of techniques for gastrointestinal tract reconstruction following gastrectomy on pancreatic beta-sell function in patients with type 2 diabetes mellitus. Zhonghua Wei Chang Wai Ke Za Zhi 14:415-418
6. Yang J, Li C, Liu H, Gu H, Chen P, Liu B (2010) Effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of type 2 diabetes mellitus. J Surg Res 164:e67-e71
7. Zervos EE, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, Rotondo MF, Pories WJ (2010) Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 210:564-572
8. Herbella FA, Tineli AC, Wilson JL Jr, Del Grande JC (2009) Duodenal bypass does not decrease glucose levels of lean individuals with gastric cancer submitted to partial or total gastrectomy. Arq Gastroenterol 46:230-232
9. Lee W, Ahn SH, Lee JH, Park do J, Lee HJ, Kim HH, Yang HK (2012) Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus. Obes Surg 22:1238-1243
10. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62-S69
11. Kim JW, Cheong JH, Hyung WJ, Choi SH, Noh SH (2012) Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol 18:49-54
12. Kowall B, Rathmann W, Heier M, Holle R, Peters A, Thorand B, Herder C, Strassburger K, Giani G, Meisinger C (2012) Impact of weight and weight change on normalization of prediabetes and on persistence of normal glucose tolerance in an older population: the KORA S4/F4 study. Int J Obes (Lond) 36:826-833
13. Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY, Chen TL, Oiu YP, Chen PP, Li WJ, Xu LY, Li EM, Tam JP, Oi RZ, Jia W, Xie D (2010) A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics 9:2617-2628
14. Sjostrom L, Lindroos AK, Peltonen M, Hohenberger W, Husemann B, Horbach T (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683-2693
15. Gunther K, Vollmuth J, Weissbach R, Hohenberger W, Huseman B, Horbach T (2006) Weight reduction after an early version of the open gastric bypass for morbid obesity: results after 23 years. Obes Surg 16:288-296
16. Ferrannini E, Gastaldelli A, Iozzo P (2011) Pathophysiology of prediabetes. Med Clin N Am 95:327-339
17. 2. Surg Obes Relat Dis 6:296-304
18. Boza C, Muñoz R, Yung E, Milone L, Gagner M (2011) Sleeve gastrectomy with ileal transposition (SGIT) induces significant weight loss and diabetes improvement without exclusion of the proximal intestine. J Gastrointest Surg 15:928-934
19. Cohen RV, Rubino F, Schiavon C, Cummings DE (2012) Diabetes remission without weight loss after duodenal bypass surgery. Surg Obes Relat Dis 8(5):e66-e68
20. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, Tsai MH, Chuang LM (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143-148
21. Talbot P, Dunbar MJ (2011) Nova Scotia Prediabetes Project: upstream screening and community intervention for prediabetes and undiagnosed type 2 diabetes. Chronic Dis Inj Can 32:2-11
22. Onat A, Can G, Cicek G, Ayhan E, Dogan Y, Kaya H (2011) Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes and coronary disease in non-diabetic adults. Acta Diabetol. doi: 10.1007/s00592-011-0313-x